| 000 | 01583 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516013802.0 | ||
| 264 | 0 | _c20110329 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1872-9061 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJansen, H J | |
| 245 | 0 | 0 |
_aPronounced weight gain in insulin-treated patients with type 2 diabetes mellitus is associated with an unfavourable cardiometabolic risk profile. _h[electronic resource] |
| 260 |
_bThe Netherlands journal of medicine _cNov 2010 |
||
| 300 |
_a359-66 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBody Fat Distribution |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aDiabetes Complications |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlycated Hemoglobin |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
| 650 | 0 | 4 |
_aInsulin _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetabolic Diseases _xepidemiology |
| 650 | 0 | 4 |
_aMetformin _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMotor Activity |
| 650 | 0 | 4 |
_aNetherlands _xepidemiology |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aWeight Gain _xdrug effects |
| 700 | 1 | _aVervoort, G | |
| 700 | 1 | _avan der Graaf, M | |
| 700 | 1 | _aTack, C J | |
| 773 | 0 |
_tThe Netherlands journal of medicine _gvol. 68 _gno. 11 _gp. 359-66 |
|
| 999 |
_c20408557 _d20408557 |
||